http://www.advfn.com/nasdaq/rss.asp?symbol=SVNT Savient Company Newsfeed en Mon, 09 Jul 2012 12:50:13 EDT Mon, 09 Jul 2012 12:50:13 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=53311529&headline=savient-to-reduce-work-force-in-restructuring http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=53311529&headline=savient-to-reduce-work-force-in-restructuring <div class='newsbody'><p> Savient Pharmaceuticals Inc. (SVNT) unveiled plans to reduce the size of its work force by more than a third as it aims to reduce its operating costs, and the specialty biopharmaceutical company also named the head of its North American commercial business as its new president... Mon, 09 Jul 2012 12:50:13 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=53310683&headline=savient-to-reduce-work-force-by-35-in-restructuring-names-new http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=53310683&headline=savient-to-reduce-work-force-by-35-in-restructuring-names-new <div class='newsbody'><pre> By Tess Stynes </pre> <p> Savient Pharmaceuticals Inc. (SVNT) unveiled plans to reduce the size of its work force by more than a third as it aims to reduce its operating costs, and the specialty biopharmaceutical company also named the head of its North American commercial... Mon, 09 Jul 2012 12:34:40 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=50986342&headline=dendreon-picks-savient-ceo-johnson-to-succeed-gold-at-helm http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=50986342&headline=dendreon-picks-savient-ceo-johnson-to-succeed-gold-at-helm <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Dendreon Corp. (DNDN) picked John H. Johnson, the chief executive and president of Savient Pharmaceuticals Inc. (SVNT), to succeed longtime President and CEO Mitchell H. Gold. </p> <p> Gold, who has been president and CEO for nearly a decade, will... Wed, 01 Feb 2012 07:41:49 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=47015141&headline=savient-pharma-shares-jump-on-veterans-affairs-contract http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=47015141&headline=savient-pharma-shares-jump-on-veterans-affairs-contract <div class='newsbody'><pre> By Thomas Gryta and Corrie Driebusch Of DOW JONES NEWSWIRES </pre> <p> NEW YORK -(Dow Jones)- Savient Pharmaceuticals Inc.'s (SVNT) shares rose 5% after the drug maker disclosed getting a contract with the U.S. Department of Veterans Affairs to supply two products for five... Thu, 24 Mar 2011 14:57:09 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=44385368&headline=savient-pharma-balances-launching-drug-selling-self http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=44385368&headline=savient-pharma-balances-launching-drug-selling-self <div class='newsbody'><pre> By Thomas Gryta Of DOW JONES NEWSWIRES </pre> <p> NEW YORK -(Dow Jones)- Savient Pharmaceuticals Inc. (SVNT) is making the unusual move of launching its newly approved gout treatment, while attempting to sell itself, all without raising cash. </p> <p> The East Brunswick, N.J... Wed, 15 Sep 2010 15:29:24 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=44369367&headline=fda-approves-savient-pharmas-gout-drug-krystexxa http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SVNT&article=44369367&headline=fda-approves-savient-pharmas-gout-drug-krystexxa <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> The Food and Drug Administration said it approved Savient Pharmaceuticals Inc.'s (SVNT) drug Krystexxa to treat gout in adults who do not respond to or cannot tolerate conventional therapy. </p> <p> The approval was expected after the biopharmaceutical... Tue, 14 Sep 2010 18:14:06 EDT